Hospitals’ performance on most quality measures was improving before the Hospital Value-Based Purchasing program began in October 2012 and did not noticeably change during the first two years of the VBP Program, according to a new  by the Government Accountability Office. “While the HVBP program aims to provide an incentive to improve hospitals’ quality of care, preliminary analysis of information from 2013 and 2014…shows that it did not noticeably alter the existing trends in hospitals’ performance on any of the quality measures used to determine HVBP payment adjustments that we examined,” GAO said. Most of the roughly 3,000 inpatient prospective payment system hospitals eligible for the VBP program received a bonus or penalty of less than 0.5% of applicable Medicare payments in each of the first three years of the program, GAO said. Safety net hospitals consistently had lower median payment adjustments – that is, smaller bonuses or larger penalties – than hospitals overall in the first three years of the program, GAO said, although the gap narrowed over time. Small urban hospitals had higher median payment adjustments each year than hospitals overall, and small rural hospitals’ median payment adjustments were similar to hospitals overall in the first two years and higher in the most recent year. The agency was required to issue the interim report to Congress by Oct. 1 under the Affordable Care Act, and must issue a final report by July 1, 2017. 

Related News Articles

Headline
Leaders from the Centers for Medicare & Medicaid Services at the 2025 AHA Annual Membership Meeting May 5 discussed issues on the agency’s agenda in a…
Headline
The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge…
Headline
The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress’ formula for…
Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…